Genetic Analysis Of Alzheimer s Disease
$409,126ZIAFY2009AGNIH
National Institute On Aging
Investigators
Linked publications & trials
Paper 31417202Paper 30706571Paper 30102995Paper 29544907Paper 29379882Paper 29329552Paper 29181857Paper 29103623Paper 27939698Paper 27776828Paper 27524508Paper 27289440Paper 27249223Paper 26803359Paper 26643944Paper 25687773Paper 25607358Paper 25104557Paper 24973356Paper 24880964Paper 24794858Paper 24439484Paper 24336208Paper 23921447Paper 23428180Paper 23360175Paper 23318515Paper 22795969Paper 22723018Paper 22503161Paper 22349451Paper 22216764Paper 22153900Paper 22027014Paper 21887711Paper 21654062Paper 21460840Paper 21085570Paper 20534741Paper 20460622Paper 20209083Paper 20020531Paper 19734902Paper 19571725Paper 19271249Paper 18667258Paper 18661559Paper 18387709Paper 16914853Paper 16472206Paper 16042549Paper 16042548Paper 15740841Paper 15668448Paper 15464261Paper 15165693Paper 14976159Paper 14746507Paper 14688411Paper 12846985Paper 12810495Paper 12794314Paper 12714109Paper 12566161Paper 12231449Paper 12177383Paper 12141310Paper 12130773Paper 12034808Paper 11983299Paper 11920850Paper 11911995Paper 11897170Paper 11895378Paper 11706935Paper 11684347Paper 11680797Paper 11425935Paper 11406330Paper 11379823Paper 11140686Paper 11079548Paper 11056541Paper 11027672Paper 11018310Paper 11001930Paper 10720282
Abstract
The primary effort within the past year has centered on using novel genetic approaches to understand the basis of Alzheimer's disease. We have used high density SNP genotyping in an attempt to identify regions that may contain recessive mutations or risk factors causing or contributing to disease. This has involved analysis of individual families in addition to work on larger cohorts. In addition we have contributed toward the most recently published genome wide association study in Alzheimer's disease that describes CLU and PICALM variants as significant risk loci for Alzheimer's disease.
View original record on NIH RePORTER →